We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Characterization of Brain Metastases

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00184275
First Posted: September 16, 2005
Last Update Posted: March 7, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
The Royal Norwegian Ministry of Health
Information provided by (Responsible Party):
Norwegian University of Science and Technology
September 13, 2005
September 16, 2005
March 7, 2014
May 2005
May 2007   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00184275 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Characterization of Brain Metastases
Brain Metastases Tissue Characterized by High-resolution Magic Angle Spinning MR and Micro Array
The purpose is to characterize tumour biological markers in brain metastases tissue from patients with different primary tumour by using ex vivo techniques as high-resolution magic angle spinning MR spectroscopy and micro array.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
frozen tumor tissue samples
Non-Probability Sample
patients with brain metastases
  • Neoplasm Metastasis
  • Lung Neoplasms
  • Breast Neoplasms
  • Melanoma
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
26
December 2010
May 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of brain metastases

Exclusion Criteria:

  • children
  • pregnancy
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT00184275
12621
No
Not Provided
Not Provided
Norwegian University of Science and Technology
Norwegian University of Science and Technology
The Royal Norwegian Ministry of Health
Study Director: Steinar Lundgren, MD PhD Cancer Clinic, St.Olavs Hospital Trondheim University Hospital
Study Chair: Ingrid S Gribbestad, PhD Norwegian University of Science and Technology, Faculty of Medicine
Norwegian University of Science and Technology
March 2014